Core Viewpoint - Baijin Life Sciences (01466.HK) has announced a delay in the publication of its 2025 annual results due to a longer-than-expected handover process following changes in the management of its subsidiary [1] Group 1: Announcement Details - The company has stated that it has only recently gained full control over the operations of its subsidiary, which has contributed to the delay in the annual results [1] - The expected publication date for the 2025 annual results is set for July 25, 2025 [1] Group 2: Trading Suspension - According to Listing Rule 13.5, if the issuer fails to publish periodic financial information as required, the stock exchange typically requires a suspension of trading in the issuer's securities [1] - If the company does not announce the 2025 annual results by June 30, 2025, trading of its shares is expected to be suspended starting from 9:00 AM on July 2, 2025 [1]
佰金生命科学：延迟刊发2025年度业绩及暂停买卖